| Product Code: ETC13340674 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa mRNA Therapeutics Contract Development Manufacturing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Africa mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 Africa mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Africa mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 Africa mRNA Therapeutics Contract Development Manufacturing Market, 2021 - 2031 |
6.1 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Process Development, 2021 - 2031 |
6.1.3 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Analytical Testing, 2021 - 2031 |
6.1.4 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
6.1.5 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Formulation Development, 2020 - 2028 |
6.1.6 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Regulatory Support, 2020 - 2028 |
6.2 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Vaccines, 2021 - 2031 |
6.2.3 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Therapeutics, 2021 - 2031 |
6.2.4 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031 |
6.2.5 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.6 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Protein Replacement Therapy, 2020 - 2028 |
6.3 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3.3 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Cancer Treatment, 2021 - 2031 |
6.3.4 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Rare Diseases, 2021 - 2031 |
6.3.5 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.3.6 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Autoimmune Diseases, 2021 - 2031 |
6.4 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.3 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.4.4 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Contract Manufacturing Organizations, 2020 - 2028 |
6.4.5 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.6 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Clinical Research Organizations, 2020 - 2028 |
6.5 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Lipid Nanoparticles, 2020 - 2028 |
6.5.3 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By In Vitro Transcription, 2020 - 2028 |
6.5.4 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Encapsulation Methods, 2020 - 2028 |
6.5.5 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By CRISPR Technology, 2020 - 2028 |
6.5.6 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By AI-Based Quality Control, 2020 - 2028 |
7 Africa mRNA Therapeutics Contract Development Manufacturing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.1 South Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.2 Egypt mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.3 Nigeria mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.4 Rest of Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.3 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 South Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Egypt mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 Nigeria mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.4 Rest of Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 South Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Egypt mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Nigeria mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.4 Rest of Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 South Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Egypt mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Nigeria mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Rest of Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 South Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Egypt mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Nigeria mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.4 Rest of Africa mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Africa mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
9 Africa mRNA Therapeutics Contract Development Manufacturing Market - Export/Import By Countries Assessment |
10 Africa mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
10.1 Africa mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10.3 Africa mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 Africa mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 Africa mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 Africa mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Africa mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
11.1 Africa mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2022 |
11.2 Africa mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here